{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:51:43Z","timestamp":1791431503845,"version":"4.3.3"},"reference-count":19,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","valueinhealthjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Value in Health"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/j.jval.2025.08.003","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T07:57:26Z","timestamp":1755503846000},"page":"73-81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Application of International Reference Pricing Rules to Forecast Pharmaceutical Launch Prices in 5 European Countries"],"prefix":"10.1016","volume":"29","author":[{"given":"Milena","family":"Izmirlieva","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jval.2025.08.003_bib1","doi-asserted-by":"crossref","DOI":"10.3402\/jmahp.v3.27675","article-title":"Overview of external reference pricing systems in Europe","volume":"3","author":"R\u00e9muzat","year":"2015","journal-title":"J Mark Access Health Policy"},{"key":"10.1016\/j.jval.2025.08.003_bib2","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.vhri.2019.04.003","article-title":"External reference pricing for pharmaceuticals\u2013a survey and literature review to describe best practices for countries with expanding healthcare coverage","volume":"19","author":"Holtorf","year":"2019","journal-title":"Value Health Reg Issues"},{"issue":"1","key":"10.1016\/j.jval.2025.08.003_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10198-019-01116-4","article-title":"Does external reference pricing deliver what it promises? Evidence on its impact at national level","volume":"21","author":"Kanavos","year":"2019","journal-title":"Eur J Health Econ"},{"key":"10.1016\/j.jval.2025.08.003_bib5","series-title":"Study on enhanced cross-country coordination in the area of pharmaceutical product pricing\u2013final report","author":"Vogler","year":"2015"},{"key":"10.1016\/j.jval.2025.08.003_bib6","series-title":"Pharmaceutical pricing and reimbursement policies in 47 PPRI network member countries","author":"Vogler","year":"2019"},{"issue":"3","key":"10.1016\/j.jval.2025.08.003_bib7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1023\/A:1025384819575","article-title":"Differential pricing for pharmaceuticals: reconciling access, R&D and patents","volume":"3","author":"Danzon","year":"2003","journal-title":"Int J Health Care Fin Econ"},{"key":"10.1016\/j.jval.2025.08.003_bib8","author":"Kanavos"},{"issue":"1","key":"10.1016\/j.jval.2025.08.003_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40258-015-0182-5","article-title":"The end of the international reference pricing system?","volume":"14","author":"Persson","year":"2015","journal-title":"Appl Health Econ Health Policy"},{"key":"10.1016\/j.jval.2025.08.003_bib10","author":"Houy"},{"key":"10.1016\/j.jval.2025.08.003_bib11","author":"Newton"},{"issue":"4","key":"10.1016\/j.jval.2025.08.003_bib12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2165\/00148365-200605040-00005","article-title":"Impact of cross-reference pricing on pharmaceutical prices. manufacturers\u2019 pricing strategies and price regulation","volume":"5","author":"Stargardt","year":"2006","journal-title":"Appl Health Econ Health Policy"},{"issue":"1","key":"10.1016\/j.jval.2025.08.003_bib13","doi-asserted-by":"crossref","DOI":"10.1080\/20016689.2017.1369817","article-title":"The perverse impact of external reference pricing (ERP): a comparison of orphan drugs affordability in 12 European countries. A call for policy change","volume":"5","author":"Young","year":"2017","journal-title":"J Mark Access Health Policy"},{"issue":"1","key":"10.1016\/j.jval.2025.08.003_bib14","first-page":"38","article-title":"Discounts and rebates granted to public payers for medicines in European countries","volume":"5","author":"Vogler","year":"2012","journal-title":"South Med Rev"},{"key":"10.1016\/j.jval.2025.08.003_bib15","article-title":"External reference pricing of medicinal products: simulation-based considerations for cross-country coordination\u2013final report","author":"Toumi","year":"2014","journal-title":"European Commission"},{"issue":"2","key":"10.1016\/j.jval.2025.08.003_bib16","first-page":"34","article-title":"Impact of external price referencing on medicine prices\u2013a price comparison among 14 European countries","volume":"5","author":"Leopold","year":"2012","journal-title":"South Med Rev"},{"issue":"2-3","key":"10.1016\/j.jval.2025.08.003_bib17","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.healthpol.2006.07.007","article-title":"A pricing policy towards the sourcing of cheaper drugs in Cyprus","volume":"81","author":"Merkur","year":"2007","journal-title":"Health Policy"},{"issue":"3","key":"10.1016\/j.jval.2025.08.003_bib18","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.hlpt.2017.06.005","article-title":"Development and performance of the external reference pricing system in Slovenia from 2007 to 2012","volume":"6","author":"Mar\u0111etko","year":"2017","journal-title":"Health Policy Technol"},{"issue":"2","key":"10.1016\/j.jval.2025.08.003_bib19","doi-asserted-by":"crossref","first-page":"79","DOI":"10.5639\/gabij.2015.0402.017","article-title":"Pharmaceutical pricing in Croatia: a comparison of ordinances in 2013 versus 2009 and their potential savings to provide future guidance","volume":"4","author":"Sovi\u0107 Brki\u010di\u0107","year":"2015","journal-title":"GaBI J"},{"key":"10.1016\/j.jval.2025.08.003_bib20","series-title":"Industrial and Business Forecasting Methods: A Practical Guide to Exponential Smoothing and Curve Fitting","author":"Lewis","year":"1982"}],"container-title":["Value in Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109830152502515X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S109830152502515X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T03:07:13Z","timestamp":1791428833000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S109830152502515X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S109830152502515X"],"URL":"https:\/\/doi.org\/10.1016\/j.jval.2025.08.003","relation":{},"ISSN":["1098-3015"],"issn-type":[{"value":"1098-3015","type":"print"}],"subject":[],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Application of International Reference Pricing Rules to Forecast Pharmaceutical Launch Prices in 5 European Countries","name":"articletitle","label":"Article Title"},{"value":"Value in Health","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jval.2025.08.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 International Society for Pharmacoeconomics and Outcomes Research, Inc. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}